Alain Fischer

发表

Analysis of risk factors for myelodysplasias, leukemias and death from infection among patients with congenital neutropenia. Experience of the French Severe Chronic Neutropenia Study Group.

Bertrand Joly, Olivier Hermine, Thierry Lamy, 2005, Haematologica.

Interaction of HIV gp120 and anti‐CD4 antibodies with the CD4 molecule on human CD4+ T cells inhibits the binding activity of NF‐AT, NF‐χB and AP‐1, three nuclear factors regulating interleukin‐2 gene enhancer activity

Nada Jabado, Claire Hivroz, A. Fischer, 1994, European journal of immunology.

The last 80 years in primary immunodeficiency: how far have we come, how far need we go?

A. Fischer, W. Shearer, Alain Fischer, 2006, The Journal of allergy and clinical immunology.

Primary immunodeficiency diseases: an update from the International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee.

Shigeaki Nonoyama, Mary Ellen Conley, Luigi D Notarangelo, 2007, The Journal of allergy and clinical immunology.

Outcomes following gene therapy in patients with severe Wiskott-Aldrich syndrome.

Frederic D Bushman, Fulvio Mavilio, Anne Galy, 2015, JAMA.

Phosphoinositide 3-Kinase δ Gene Mutation Predisposes to Respiratory Infection and Airway Damage

Nada Jabado, James Curtis, Sergey Nejentsev, 2013, Science.

ZAP70: a master regulator of adaptive immunity

Capucine Picard, Claire Hivroz, A. Fischer, 2010, Seminars in Immunopathology.

Dynamics of gene-modified progenitor cells analyzed by tracking retroviral integration sites in a human SCID-X1 gene therapy trial.

Frederic D. Bushman, Philippe Leboulch, Nirav Malani, 2010, Blood.

Chronic Granulomatous Disease: The European Experience

Dirk Roos, Theoni Petropoulou, A. Fischer, 2009, PloS one.

Clinical spectrum and features of activated phosphoinositide 3-kinase δ syndrome: A large patient cohort study

Bodo Grimbacher, James Curtis, Siobhan O. Burns, 2017, The Journal of allergy and clinical immunology.

Transfusion independence and HMGA2 activation after gene therapy of human β-thalassaemia

Jérôme Larghero, Kenneth Cornetta, Philippe Leboulch, 2010, Nature.

Vector integration is nonrandom and clustered and influences the fate of lymphopoiesis in SCID-X1 gene therapy.

Bruce Aronow, Christof von Kalle, Jean Weissenbach, 2007, The Journal of clinical investigation.

Three novel mutations of the CIITA gene in MHC class II-deficient patients with a severe immunodeficiency

Dominique Charron, Capucine Picard, A. Fischer, 2002, Immunogenetics.

A human immunodeficiency caused by mutations in the PIK3R1 gene.

Patrick Nitschke, Felipe Suarez, Sven Kracker, 2015, The Journal of clinical investigation.

Hematopoietic Stem Cell Gene Therapy with a Lentiviral Vector in X-Linked Adrenoleukodystrophy

Manfred Schmidt, Philippe Leboulch, Cynthia C. Bartholomae, 2009, Science.

Health in Action Open access, freely available online The European Rare Diseases Therapeutic Initiative A public–private partnership is promoting research on new treatments for rare diseases

A. Fischer, Alain Fischer, Pascale Borensztein, 2022 .

Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients

Nicolas Carlier, Aurélien Corneau, Nicolas Roche, 2020, Science.

Somatic Hypermutation Shapes the Antibody Repertoire of Memory B Cells in Humans

Michel C. Nussenzweig, A. Fischer, M. Nussenzweig, 2001, The Journal of experimental medicine.

A human immunodeficiency caused by mutations in the PIK3R1 gene.

Patrick Nitschke, Felipe Suarez, Sven Kracker, 2014, The Journal of clinical investigation.

A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency.

Christof von Kalle, Manfred Schmidt, Salima Hacein-Bey-Abina, 2003, The New England journal of medicine.

Deficient Peptide Loading and MHC Class II Endosomal Sorting in a Human Genetic Immunodeficiency Disease: the Chediak-Higashi Syndrome

Sebastian Amigorena, Graça Raposo, A. Fischer, 1998, The Journal of cell biology.

Efficacy of gene therapy for X-linked severe combined immunodeficiency.

Frederic D. Bushman, Lily E. Leiva, Capucine Picard, 2010, The New England journal of medicine.

A modified γ-retrovirus vector for X-linked severe combined immunodeficiency.

Christopher Baum, David A. Williams, Gregory Hopkins, 2014, The New England journal of medicine.